Skip to main content
. 2017 Nov 8;39(3):407–417. doi: 10.1093/carcin/bgx122

Figure 3.

Figure 3.

Expression of RAD51AP1 (panels A and E), FSTL1 (panels B and F), COL12A1 (panels C and G), SPRR1A (panels D and H) in ovarian (A-D) and lung (E-H) cancers compared with healthy controls. *P < 0.05, **P < 0.01 and ***P < 0.001.